<DOC>
	<DOC>NCT00993005</DOC>
	<brief_summary>The purpose of the study is to assess the efficacy of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of Hypertrophic scars and keloids. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of persons to be recruited and randomized for the study is 90.</brief_summary>
	<brief_title>CICATRIX in the Treatment of Hypertrophic Scars and Keloids Scars</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Cicatrix</mesh_term>
	<mesh_term>Cicatrix, Hypertrophic</mesh_term>
	<criteria>Hypertrophic wound or keloid with no treatment for more than 1 month. Signed informed consent. Usage of steroids within 30 days. Malignant neoplastic conditions. Alcoholism. Handicap and/or psychiatric condition preventing treatment accomplishment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Hypertrophic scars</keyword>
	<keyword>Keloids</keyword>
	<keyword>Asian Gotu Kola</keyword>
	<keyword>Asian Pennywort</keyword>
</DOC>